Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, told U.S. senators during his ...

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...

Robert F. Kennedy Jr. vows to finalize regulations for greater diverse patient involvement in clinical trials during his ...

The US Food and Drug Administration (FDA) recently issued a notice of noncompliance to the FADOI Foundation, citing the ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

In the EU, the AI Act has been approved, carrying significant implications for medical device, technology, and pharmaceutical firms. In the US, ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

"Poor representation in clinical trials reduces our understanding ... It was still accessible on the U.S. government's regulation.gov website. The FDA declined to comment, citing a pause on ...

Although it remains uncertain whether PROMs will realize their potential, Hoffman and Podgurski offer these proposals as ...

Two top clinicians have been disciplined amid growing concern that Kaiser’s system for monitoring research safety and ethics ...

While experts across the political spectrum are generally in favor of stricter regulations ... big changes at the FDA do not bode well for scientific advancement: “Research could be delayed ...